Analyze Diet
Journal of leukocyte biology1998; 63(3); 380-388; doi: 10.1002/jlb.63.3.380

Priming induces functional coupling of N-formyl-methionyl-leucyl-phenylalanine receptors in equine neutrophils.

Abstract: The synthetic formylpeptide fMLP is widely used as a model chemoattractant and secretagogue for mammalian neutrophils. Despite possessing fMLP receptors, equine neutrophils do not produce superoxide anions in response to fMLP and there is no inflammatory reaction in the horse when fMLP is injected intradermally. The functional capability of these receptors was investigated after pretreatment with recognized priming agents. Purified neutrophils were pretreated with lipopolysaccharide (LPS), platelet-activating factor (PAF), or tumor necrosis factor alpha (TNF-alpha) and superoxide anion generation and shape change quantified by lucigenin-dependent chemiluminescence (LDCL) and flow cytometry, respectively. LPS, TNF-alpha, and PAF pretreatment induced significant LDCL in response to fMLP; similarly LPS pretreatment was a prerequisite for fMLP-stimulated neutrophil polarization in response to fMLP. However, LPS failed to induce fMLP-mediated chemotaxis of equine neutrophils. These data indicate that equine neutrophil fMLP receptors are not vestigial as previously thought but can trigger both respiratory burst activity and cell polarization responses after priming.
Publication Date: 1998-03-21 PubMed ID: 9500527DOI: 10.1002/jlb.63.3.380Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This study delves into the understanding of how priming agents can trigger function in equine neutrophil fMLP receptors, leading to responses such as respiratory burst activity and cell polarization.

Introduction to the Research

  • This research was geared towards understanding the functional capabilities of N-formyl-methionyl-leucyl-phenylalanine (fMLP) receptors in equine neutrophils.
  • fMLP is typically used as a standard chemoattractant and secretagogue in experiments involving mammalian neutrophils. However, when exposed to fMLP, equine neutrophils do not produce superoxide anions, and there is no inflammatory reaction in horses.

Methodology and Findings

  • The research started by pretreating purified neutrophils with recognized priming agents such as lipopolysaccharide (LPS), platelet-activating factor (PAF), or tumor necrosis factor alpha (TNF-alpha).
  • Once the pretreatment was done, the generation of superoxide anion and shape change in neutrophils was measured using a method called lucigenin-dependent chemiluminescence (LDCL) and flow cytometry techniques.
  • The results showed that priming with LPS, TNF-alpha, and PAF induced significant LDCL in response to fMLP.
  • Moreover, it was found that LPS pretreatment was necessary for neutrophil polarization in response to fMLP. In other words, neutrophils exhibited a change in shape or polarization when exposed to fMLP but only after being subjected to LPS pretreatment.
  • However, despite the observed responses, the LPS priming did not lead to chemotaxis (the process where cells move in response to chemical stimulation) of equine neutrophils in response to fMLP.

Conclusion

  • The study concluded by indicating that equine neutrophil fMLP receptors, contrary to previous assumptions, are not vestigial but instead, they can activate respiratory burst activity and cell polarization after being primed.

Cite This Article

APA
Brazil TJ, Rossi AG, Haslett C, McGorum B, Dixon PM, Chilvers ER. (1998). Priming induces functional coupling of N-formyl-methionyl-leucyl-phenylalanine receptors in equine neutrophils. J Leukoc Biol, 63(3), 380-388. https://doi.org/10.1002/jlb.63.3.380

Publication

ISSN: 0741-5400
NlmUniqueID: 8405628
Country: England
Language: English
Volume: 63
Issue: 3
Pages: 380-388

Researcher Affiliations

Brazil, T J
  • Department of Medicine (RIE), University of Edinburgh Medical School, United Kingdom.
Rossi, A G
    Haslett, C
      McGorum, B
        Dixon, P M
          Chilvers, E R

            MeSH Terms

            • Animals
            • Chemotaxis, Leukocyte / drug effects
            • Chemotaxis, Leukocyte / physiology
            • Horses
            • Kinetics
            • Lipopolysaccharides / pharmacology
            • Luminescent Measurements
            • N-Formylmethionine Leucyl-Phenylalanine / blood
            • N-Formylmethionine Leucyl-Phenylalanine / pharmacology
            • Neutrophils / cytology
            • Neutrophils / drug effects
            • Neutrophils / physiology
            • Receptors, Formyl Peptide
            • Receptors, Immunologic / physiology
            • Receptors, Peptide / physiology
            • Superoxides / blood
            • Tumor Necrosis Factor-alpha / pharmacology

            Grant Funding

            • Wellcome Trust

            Citations

            This article has been cited 5 times.
            1. Brazil TJ, Dixon PM, Haslett C, Murray J, McGorum BC. Constitutive apoptosis in equine peripheral blood neutrophils in vitro. Vet J 2014 Dec;202(3):536-42.
              doi: 10.1016/j.tvjl.2014.08.029pubmed: 25239298google scholar: lookup
            2. Nakata M, Otsubo K, Kikuchi T, Itou T, Sakai T. Chemotactic properties and absence of the formyl peptide receptor in ferret (Mustela putorius furo) neutrophils. Res Vet Sci 2010 Feb;88(1):56-60.
              doi: 10.1016/j.rvsc.2009.05.019pubmed: 19539964google scholar: lookup
            3. Ye RD, Boulay F, Wang JM, Dahlgren C, Gerard C, Parmentier M, Serhan CN, Murphy PM. International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol Rev 2009 Jun;61(2):119-61.
              doi: 10.1124/pr.109.001578pubmed: 19498085google scholar: lookup
            4. Iribarren P, Zhou Y, Hu J, Le Y, Wang JM. Role of formyl peptide receptor-like 1 (FPRL1/FPR2) in mononuclear phagocyte responses in Alzheimer disease. Immunol Res 2005;31(3):165-76.
              doi: 10.1385/IR:31:3:165pubmed: 15888909google scholar: lookup
            5. Burns JA, Issekutz TB, Yagita H, Issekutz AC. The beta2, alpha4, alpha5 integrins and selectins mediate chemotactic factor and endotoxin-enhanced neutrophil sequestration in the lung. Am J Pathol 2001 May;158(5):1809-19.
              doi: 10.1016/s0002-9440(10)64137-5pubmed: 11337379google scholar: lookup